These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8366188)

  • 21. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry.
    Hunyady B; Juricskay I; Nagy L; Garamszegi M; Vincze A; Mózsik G
    Eur J Clin Pharmacol; 1996; 50(6):449-56. PubMed ID: 8858270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of intravenous administration of combined acid suppressants in healthy dogs.
    Tolbert MK; Odunayo A; Howell RS; Peters EE; Reed A
    J Vet Intern Med; 2015; 29(2):556-60. PubMed ID: 25711717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early effects of intravenous administrations of lansoprazole and famotidine on intragastric pH.
    Iida H; Inamori M; Akimoto K; Mawatari H; Endo H; Nozaki Y; Akiyama T; Ikeda T; Sakamoto Y; Fujita K; Yoneda K; Takahashi H; Yoneda M; Goto A; Abe Y; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nakajima A
    Hepatogastroenterology; 2009; 56(90):551-4. PubMed ID: 19579641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
    Savarino V
    Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of famotidine, 40 mg at night, on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.
    Lanzon-Miller S; Pounder RE; Ball SG; Dalgleish DJ; Coward J; Jackson AO
    Scand J Gastroenterol; 1988 Mar; 23(2):244-50. PubMed ID: 3283919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of meal-stimulated gastric acid secretion by in vivo gastric autotitration.
    Gardner JD; Ciociola AA; Robinson M
    J Appl Physiol (1985); 2002 Feb; 92(2):427-34. PubMed ID: 11796648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does smoking influence the pharmacokinetics and pharmacodynamics of the H2-receptor antagonist famotidine?
    Baak LC; Ganesh S; Jansen JB; Lamers CB
    Br J Clin Pharmacol; 1992 Feb; 33(2):193-6. PubMed ID: 1550700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of single morning and single bedtime doses of famotidine on intragastric acidity in patients with gastric ulcer.
    Arita M; Okada M; Motomura A; Matsui T; Hosiko K; Yao T
    Am J Gastroenterol; 1994 Feb; 89(2):214-9. PubMed ID: 8304306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of automatic computerised pump to maintain constant intragastric pH.
    Hannan A; Chesner I; Merki HS; Mann S; Walt RP
    Gut; 1990 Nov; 31(11):1246-9. PubMed ID: 2253907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the effect of a famotidine continuous rate infusion on intragastric pH in healthy dogs.
    Hedges K; Odunayo A; Price JM; Hecht S; Tolbert MK
    J Vet Intern Med; 2019 Sep; 33(5):1988-1994. PubMed ID: 31294879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine.
    Ikawa K; Shimatani T; Hayato S; Morikawa N; Tazuma S
    Biol Pharm Bull; 2007 May; 30(5):1003-6. PubMed ID: 17473452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
    Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.
    Merki HS; Witzel L; Kaufman D; Kempf M; Neumann J; Röhmel J; Walt RP
    Gut; 1988 Apr; 29(4):453-7. PubMed ID: 3286384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study.
    Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G
    Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the Effect of Pre-operative Single Oral Dose of Tramadol and Famotidine on Gastric Secretions pH and Volume in Patients Scheduled for Laparoscopic Cholecystectomy.
    Khan MU; Aqil M; Hussain A; Zahrani TA; Hillis M
    J Coll Physicians Surg Pak; 2015 May; 25(5):320-3. PubMed ID: 26008654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements.
    Delchier JC; Roudot-Thoraval F; Stanescu L; Deharvengt MC; Elouaer Blanc L
    Gut; 1994 Jun; 35(6):750-4. PubMed ID: 8020798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of 7-day therapy with different doses of the proton pump inhibitor lansoprazole on the intragastric pH in healthy human subjects.
    Harder H; Teyssen S; Stephan F; Pfützer R; Kiel G; Fuchs W; Singer MV
    Scand J Gastroenterol; 1999 Jun; 34(6):551-61. PubMed ID: 10440603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status.
    Sugimoto M; Furuta T; Shirai N; Ikuma M; Hishida A; Ishizaki T
    Clin Pharmacol Ther; 2006 Nov; 80(5):539-48. PubMed ID: 17112810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.